Cost-Effectiveness Analysis of Molnupiravir Versus Best Supportive Care for the Treatment of Outpatient COVID-19 in Adults in the US미국 성인의 코로나19 외래환자 치료를 위한 몰누피라비르 대 최상의 지지 요법의 비용 효율성 분석Article Published on 2022-07-012022-09-11 Journal: PharmacoEconomics [Category] MERS, 바이오마커, 변종, [키워드] acute phase adult outpatient adult outpatients Adult patients affected Analysis Antiviral best Care changes changes in conducted coronavirus disease Coronavirus disease 2019 Cost effectiveness COVID-19 COVID-19 outpatients database de novo Decision tree decrease died dominant effective Electronic health record Electronic health records evaluated healthcare Healthcare system highest Hospitalization Hospitalized Immunity increase in information Intervention less Markov medical costs Mild-to-moderate molnupiravir outcome Outpatient pandemic parameter Patient patient population Perspective Primary outcomes Probability progression proportion real-world data reduction remained reported Research risk sensitivity analysis severe disease Society supportive care Therapies threshold transition transition probabilities treated treating COVID-19 Treatment Trial unavailability utility vaccination Viral Viral variants with COVID-19 [DOI] 10.1007/s40273-022-01168-0 PMC 바로가기 [Article Type] Article
Comparative study of SmartAmp assay and reverse transcription-polymerase chain reaction by saliva specimen for the diagnosing COVID-19코로나19 진단을 위한 타액 검체에 의한 SmartAmp assay 및 역전사-중합효소 연쇄반응 비교 연구Article Published on 2022-01-012022-09-11 Journal: Journal of infection and chemotherapy : official j [Category] SARS, 변종, 유전자 메커니즘, 진단, [키워드] Accuracy caused Chain Reaction Comparative coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 Ct-value diagnose diagnosing diagnostic Diagnostic accuracy diagnostic test False negative false-negative individual Infection Japan Mann-Whitney U test medical costs Mutation Negative predictive value new SARS-CoV-2 no significant difference not high Novel coronavirus novel coronavirus disease pandemic Patient performed polymerase chain reaction positive Positive predictive value Predictive value reduce respiratory Respiratory Coronavirus Retrospective study Reverse transcription-polymerase chain reaction rRT-PCR rRT-PCR testing Saliva SARS-CoV-2 sensitivity severe acute respiratory coronavirus severe acute respiratory coronavirus 2 SmartAmp. specificity specimen tested the disease virus [DOI] 10.1016/j.jiac.2021.09.011 PMC 바로가기 [Article Type] Article
Lopinavir/ritonavir and interferon combination therapy may help shorten the duration of viral shedding in patients with COVID-19: A retrospective study in two designated hospitals in Anhui, ChinaLopinavir/ritonavir 및 인터페론 병용 요법은 COVID-19 환자의 바이러스 배출 기간을 단축하는 데 도움이 될 수 있습니다.Multicenter Study Published on 2020-11-012022-09-11 Journal: Journal of medical virology [Category] 치료제, [키워드] 95% CI 95% confidence interval acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 addition age analyzed Antiviral treatment Associated factors China collected combination therapy coronavirus coronavirus disease coronavirus disease-2019 COVID-19 Cox proportional hazard Cox proportional hazards model cross-sectional study Delayed electronic medical records Factor hazard ratio help hospital Hospital stay Hospitalization IFN-α illness onset independent initial interferon Interferon-α interquartile range IQR Laboratory laboratory-confirmed Laboratory-confirmed COVID-19 Lopinavir Lopinavir/ritonavir male median median time medical costs medical records nothing outcome outcomes Patient patients Prolonged prolonged viral shedding proportional hazards model respiratory Retrospective cross-sectional study Retrospective study Ritonavir RNA SARS-CoV-2 SARS-CoV-2 RNA severe acute respiratory syndrome Coronavirus severity of COVID-19 shedding the mean the median Treatment Viral viral shedding Viral shedding. [DOI] 10.1002/jmv.26127 PMC 바로가기 [Article Type] Multicenter Study